Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Total 13F shares
-
36,826,198
-
Share change
-
-57,935
-
Total reported value
-
$650,671,909
-
Put/Call ratio
-
69%
-
Price per share
-
$17.69
-
Number of holders
-
104
-
Value change
-
-$42,888,185
-
Number of buys
-
65
-
Number of sells
-
45
Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q4 2021
As of 31 Dec 2021,
Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,826,198 shares.
The largest 10 holders included
FMR LLC, TRV GP III, LLC, RTW INVESTMENTS, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, TRV GP IV, LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Holocene Advisors, LP, and D. E. Shaw & Co., Inc..
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.